Enable job alerts via email!
Boost your interview chances
Create a job specific, tailored resume for higher success rate.
An established industry player is seeking an Associate Director of Commercial Insights and Analytics to enhance its innovative pipeline. This pivotal role involves providing strategic insights that will shape the future of therapies targeting debilitating diseases. You will conduct thorough market assessments, synthesize complex data, and collaborate with cross-functional teams to drive strategic decisions. If you have a strong background in biopharmaceuticals and a passion for improving patient outcomes, this opportunity offers a chance to make a significant impact in the healthcare landscape. Join a team dedicated to transforming patient care through cutting-edge science and strategic foresight.
Arvinas is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC targeted protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.
In addition to its robust preclinical pipeline of PROTAC protein degraders against validated and “undruggable” targets, the company has three investigational clinical-stage programs currently enrolling: vepdegestrant for the treatment of patients with locally advanced or metastatic ER+/HER2- breast cancer; ARV-102 for the treatment of patients with neurodegenerative disorders, and ARV-393 for the treatment of patients with relapsed/refractory non-Hodgkin Lymphoma and potentially other lymphomas.
In April 2024, Arvinas entered into a transaction with Novartis, including a global license agreement for the development and commercialization of the clinical stage PROTAC androgen receptor protein degrader ARV-766 for the treatment of prostate cancer. The transaction closed in May 2024.
Position Summary
The Associate Director, Commercial Insights and Analytics, Early Pipeline. This role will be responsible for providing strategic commercial and competitive intelligence insights for preclinical and clinical programs, and new target assessments to support Arvinas’ portfolio. This includes developing a strong viewpoint on evolving treatment landscape and unmet needs, and competitive landscape for Arvinas’ preclinical and clinical programs. This role will work closely cross-functionally to answer strategic questions to advance Arvinas’ portfolio. This role offers an opportunity to help shape the strategy to deliver a new transformative drug modality to patients with high unmet needs.
This position reports to the Executive Director, Commercial Insights and Analytics, and can be located at our headquarters in New Haven, CT or work remotely from a location within the U.S.
Principal Responsibilities
Qualifications
Education
Arvinas is proud to offer a competitive package of base and incentive compensation as well as a comprehensive benefits program designed to support the health, wellness and financial security of our employees and their families. Benefits include group medical, vision and dental coverage, group and supplemental life insurance, and much more.
Arvinas is an Equal Opportunity employer.